InvestorsHub Logo
Followers 39
Posts 3283
Boards Moderated 0
Alias Born 05/26/2014

Re: None

Wednesday, 08/22/2018 8:36:52 AM

Wednesday, August 22, 2018 8:36:52 AM

Post# of 145090
I only get 1 post a day so make it count... I honestly beleive we are gonna be good.. Very Quiet.. There are a lot of articles i read and the plant is worth tons of money and not including patent s.. THere one sticks out like a soar thumb...




?

MOMENTUM & GROWTH

Bioamber Inc (OTCMKTS:BIOA) Remains in Hot Pursuit of a Turnaround Strategy

?

ByJim Bloom

Posted on April 3, 2018

 

 

 

 

 

COMMENTS

Bioamber Inc (OTCMKTS:BIOA) has not been the top pick for investors in recent times. In the last few months, its share price has tumbled from $2.11 to $0.05. However its management has remained steady in its plans to turn around the firm’s fortunes and if recent announcements are anything to go by, this may just be the time. Recent announcements of multiple profitable partnerships, an increasing client base which has translated to increased sales and a very active management have brought the firm back into the spotlight. In the piece, we provide you with some of the high points of its recent earnings call and its financial outlook.

Take a look at its share price movement over the last year.

?

BIOA Daily Chart

Company Profile

BioAmber, Inc. was established in October 2008 and its head office is situated in Montreal, Canada. The firm is an industrial biotechnology company, which specializes in the production of sustainable chemicals. Its innovative technology platform which integrates chemical catalysis and industrial biotechnology in order to transform renewable feedstock into chemicals for everyday use which includes resins, personal care products, food additives, paints, and plastics. Some of its other merchandise includes butanediol, bio-based disodium succinate, and bio-based succinic acid. For more information on the company, visit our previous post here.

Recent Developments

In the very recent fourth-quarter earnings call, the company discussed its previously announced merchandise launch with an Aqua Concept, an innovative company based in Europe. Aqua Concept is releasing a new coolant which is based on BioAmber’s own succinic acid. Besides the provision of a much more sustainable footprint, this new merchandise delivers a number of improved performance features in comparison to other products within the market. Bioamber intends to forward to grow this new effective merchandise in partnership with Aqua Concept. Interestingly, Aqua Concepts happens to be just one of the many clients who is launching new products associated with Bioamber’s bio-succinic acid which it had been working with not just in the last few months, but a number of years and the plans to boost the demand for its other products in the future.

Considering its long-term growth strategy, the firm has made major progress in entering into the animal feed sales in PET markets. These markets have a target market size estimated to be about 0.4 million and 0.7 million tons of bio-succinic acid respectively, both of which are many times above the firm’s present production capacity. Regarding animal feed, a recent independent research revealed that the addition of succinic acid to animal feed with delivers significant benefits for both gut health and growth performance for nursery pigs. This result corroborates with preceding studies by BioAmber which demonstrate the minimum inhibitory concentration, of succinic acid relating to multiple pathogenic microorganisms, is much reduced compared to the content level for other organic acids in the market which suggests that bio-succinic can be said to be more economical and effective

However, for PET, the firm’s plans to replace isophthalic acid which is currently used in roughly 3 weight percent in the production of PET bottles. Bio-succinic acid is demonstrating the ability to decrease the cost along with the greenhouse gas effect of PET bottle production. Biopharma is scaling up this innovation through collaborations with its developmental partners located in China and Europe, where the firm has had three recently fruitful scale-up trials of manufacturing PET packaging resin. This will enable the company to advance with both PET and animal feed by 2019 to the level of major industry players.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.